Related Articles
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours
Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience
Complete response to second-line chemotherapy with sunitinib of a gastrointestinal stromal tumor: A case report
Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma
Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases